To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene IL13RA1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
456 supporting clones for gene IL13RA1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB027990 testis .a 1 to 376 2 to 377   tiling clone, capped   376/376
(100 %)
4 diff
(99.0 %id)
DB458653 testis .a 253 to 730 1 to 478       478/478
(100 %)
0 diff
(100 %id)
BM788541 stomach .a 276 to 874 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
DA845286 placenta .a 277 to 853 2 to 579   capped   578/579
(99 %)
2 diff
(99.7 %id)
DB261081 uterus .a 277 to 845 2 to 571   capped   570/570
(100 %)
4 diff
(99.3 %id)
BM763177 myeloma .a 280 to 874 1 to 595       595/595
(100 %)
4 diff
(99.4 %id)
DA685427   .a 284 to 860 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AV656840 corresponding non cancerous liver tissue .a 296 to 645 1 to 350     Submitted on the opposite strand 350/393
(89 %)
28 diff
(92.9 %id)
BG822401 adenocarcinoma cell line, colon .a 296 to 898 1 to 610       610/628
(97 %)
18 diff
(97.2 %id)
BC015768 Colon, adenocarcinoma .a 297 to 2417 1 to 2121 W3C available from MGC, AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 2121/2121
(100 %)
1 diff
(100.0 %id)
CA398074 eye, RPE/choroid .a 300 to 860 1 to 561     Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 561/561
(100 %)
1 diff
(99.9 %id)
NM_001560.2   .a 301 to 4306 1 to 4006   RefSeq,   4006/4006
(100 %)
0 diff
(100 %id)
Y10659   .a 301 to 4306 1 to 4006       4006/4039
(99 %)
1 diff
(100.0 %id)
DN992380 brain, whole brain .a 302 to 868 8 to 572       565/572
(98 %)
12 diff
(98.0 %id)
U81379   .a 304 to 2008 1 to 1705       1705/1708
(99 %)
3 diff
(99.9 %id)
DA549879   .a 305 to 884 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA948525 Spleen .a 305 to 640 2 to 338   capped   337/337
(100 %)
1 diff
(99.8 %id)
DA590367 lung .a 306 to 739 2 to 436   capped   435/435
(100 %)
1 diff
(99.8 %id)
U62858   .a 306 to 1781 47 to 1522 T130I G358D     1476/1572
(93 %)
8 diff
(99.5 %id)
BG699187 brain, hippocampus .a 310 to 1069 1 to 762       762/764
(99 %)
10 diff
(98.7 %id)
BQ678245 melanotic melanoma, cell line, skin .a 310 to 1173 10 to 875       866/978
(88 %)
23 diff
(97.7 %id)
DA719134   .a 311 to 678 2 to 372   capped   371/371
(100 %)
3 diff
(99.2 %id)
Y09328   .a 311 to 4309 1 to 3999   tiling clone,   3999/3999
(100 %)
1 diff
(100.0 %id)
AK313467 hippocampus .a 312 to 1627 1 to 1316       1316/1316
(100 %)
0 diff
(100 %id)
BP267255 thyroid .a 312 to 889 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BP268026 thyroid .a 312 to 892 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
DA325930 hippocampus .a 313 to 870 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BF568398 epithelioid carcinoma cell line, Pancreas .a 313 to 767 1 to 462       462/462
(100 %)
10 diff
(97.9 %id)
DA990941 synovial membrane tissue from rheumatioidarthritis .a 313 to 843 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
BC009960 Pancreas, epithelioid carcinoma .a 314 to 2417 1 to 2104   available from MGC, AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 2104/2104
(100 %)
0 diff
(100 %id)
DA839608 placenta .a 314 to 865 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BQ066855 brain .a 322 to 528 1 to 207       207/207
(100 %)
0 diff
(100 %id)
BI464939 testis .a 327 to 1085 1 to 773       722/1009
(71 %)
28 diff
(97.3 %id)
DB061920 testis .a 330 to 879 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CN265110 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 338 to 958 1 to 621       621/621
(100 %)
1 diff
(99.9 %id)
EL733469 mixed .a 344 to 951 1 to 608       608/608
(100 %)
0 diff
(100 %id)
AB209849 aorta endothelial cell .a 346 to 4305 1 to 3960       3960/3960
(100 %)
1 diff
(100.0 %id)
AA411323 ovarian tumor, ovary .a 622 to 1154 1 to 533       533/533
(100 %)
4 diff
(99.3 %id)
TI_1948154300   .a 715 to 1626 1036 to 126       911/1440
(63 %)
19 diff
(98.7 %id)
TI_1948154125   .a 730 to 1626 1020 to 125       896/1429
(62 %)
14 diff
(99.1 %id)
TI_1948154216   .a 831 to 1626 917 to 123       795/1469
(54 %)
10 diff
(99.4 %id)
BF246168 brain, glioblastoma .a 894 to 1620 1 to 727       727/858
(84 %)
31 diff
(96.4 %id)
BG565689 Liver .a 954 to 1581 1 to 633       633/633
(100 %)
12 diff
(98.2 %id)
DA102323 cerebellum .a 962 to 1540 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
TI_1948240371   .a 1014 to 1626 1196 to 595     Submitted on the opposite strand 602/1283
(46 %)
49 diff
(96.2 %id)
CK000442 mixed .a 1019 to 1832 30 to 838       809/842
(96 %)
25 diff
(97.1 %id)
DB150552 thymus .a 1042 to 1613 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CA488843   .a 1058 to 1946 1 to 899       899/902
(99 %)
11 diff
(98.8 %id)
AW391682 stomach .a 1066 to 1585 1 to 519       519/519
(100 %)
16 diff
(97.0 %id)
AK296958 tongue, tumor tissue .a 1072 to 2037 1 to 966       966/966
(100 %)
2 diff
(99.8 %id)
DC347867 tongue, tumor tissue .a 1072 to 1629 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
AI768613 Kidney .a 1094 to 1718 624 to 1       624/624
(100 %)
3 diff
(99.6 %id)
DA294933 hippocampus .a 1102 to 1651 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA707381   .a 1116 to 1684 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA990183 synovial membrane tissue from rheumatioidarthritis .a 1122 to 1663 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
AA127509 lung, lung carcinoma .a 1131 to 1480 1 to 350   fully sequenced,   350/350
(100 %)
0 diff
(100 %id)
TI_149290515   .a 1225 to 2062 935 to 104   AAA   832/982
(84 %)
19 diff
(98.1 %id)
BE547004 cervical carcinoma cell line, cervix .a 1270 to 2010 1 to 747       747/872
(85 %)
28 diff
(96.8 %id)
DA445517 tongue, tumor tissue .a 1349 to 1929 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA358185 subthalamic nucleus .a 1368 to 1922 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB510604 testis .a 1378 to 1716 1 to 340     Submitted on the opposite strand 340/342
(99 %)
5 diff
(98.6 %id)
BU171192 melanotic melanoma, skin .a 1394 to 2261 1 to 873       873/873
(100 %)
12 diff
(98.7 %id)
DB125253 thymus .a 1395 to 1949 2 to 558   capped   557/557
(100 %)
6 diff
(99.0 %id)
DA674210   .a 1410 to 2009 2 to 601   capped   600/600
(100 %)
1 diff
(99.9 %id)
BM973496 lung .a 1411 to 2062 671 to 19   AAA   653/653
(100 %)
2 diff
(99.7 %id)
BU608413 Human Lung Epithelial cells, lung .a 1411 to 2134 741 to 19   AAA   723/723
(100 %)
2 diff
(99.8 %id)
AA127390 lung, lung carcinoma .a 1419 to 1741 347 to 18   fully sequenced, AAA   330/330
(100 %)
0 diff
(100 %id)
AI888989 2 pooled tumors (clear cell type), Kidney .a 1445 to 2068 627 to 1       627/627
(100 %)
7 diff
(98.9 %id)
AA627056 normal prostate, Prostate .a 1450 to 1902 502 to 50       453/502
(90 %)
0 diff
(100 %id)
BP385602 pancreatic islet .a 1454 to 1696 244 to 1       244/250
(97 %)
1 diff
(99.6 %id)
BP243494 Liver .a 1454 to 2022 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
DA480438   .a 1462 to 2013 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
TI_159722555   .a 1465 to 2134 752 to 84   AAA   669/1019
(65 %)
3 diff
(99.8 %id)
CA944522 Human Lung Epithelial cells, lung .a 1465 to 2134 687 to 19   AAA   669/679
(98 %)
3 diff
(99.6 %id)
AW168100 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1472 to 2061 588 to 1       588/588
(100 %)
23 diff
(96.1 %id)
BG169562 hypernephroma, cell line, Kidney .a 1475 to 2225 1 to 742       742/1072
(69 %)
15 diff
(98.7 %id)
BM903644 ovary (pool of 3) .a 1488 to 2134 10 to 657       648/657
(98 %)
1 diff
(99.9 %id)
BQ306154 breast .a 1489 to 1619 130 to 1       130/130
(100 %)
1 diff
(99.3 %id)
AI401218 brain, glioblastoma (pooled) .a 1534 to 2134 605 to 5       601/673
(89 %)
0 diff
(100 %id)
TI_149314048   .a 1534 to 2134 692 to 92   AAA   601/970
(61 %)
2 diff
(99.8 %id)
CB305848 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1560 to 2134 593 to 19   AAA   575/575
(100 %)
1 diff
(99.9 %id)
AI816791 2 pooled tumors (clear cell type), Kidney .a 1571 to 2134 571 to 8       564/571
(98 %)
0 diff
(100 %id)
CN265108 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1574 to 1949 1 to 377       377/377
(100 %)
2 diff
(99.5 %id)
BF569171 epithelioid carcinoma cell line, Pancreas .a 1592 to 2393 840 to 25       816/1238
(65 %)
0 diff
(100 %id)
AA548700 normal prostatic epithelial cells, Prostate .a 1594 to 1967 1 to 373       373/373
(100 %)
7 diff
(98.2 %id)
DB200938 trachea .a 1604 to 2187 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BP291652 lung .a 1607 to 2184 1 to 578       578/583
(99 %)
2 diff
(99.7 %id)
DA549737   .a 1608 to 2170 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA642354 Liver .a 1608 to 2246 2 to 640   capped   639/639
(100 %)
0 diff
(100 %id)
AA411324 ovarian tumor, ovary .a 1615 to 2088 485 to 12   AAA   474/474
(100 %)
0 diff
(100 %id)
AW291365   .a 1619 to 2134 532 to 18   AAA   515/515
(100 %)
1 diff
(99.9 %id)
BU954075 mixed (pool of 40 RNAs) .a 1643 to 1787 1 to 145   AAA   145/145
(100 %)
2 diff
(98.7 %id)
AW238231 carcinoma in situ from retromolar trigone .a 1665 to 2082 9 to 426     Submitted on the opposite strand 418/426
(98 %)
6 diff
(98.6 %id)
CA406186 adipose .a 1666 to 2171 1 to 505       505/505
(100 %)
2 diff
(99.7 %id)
DA647769   .a 1678 to 2202 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
AW006651 colon .a 1692 to 2134 444 to 2       443/444
(99 %)
0 diff
(100 %id)
DA880932   .a 1733 to 2288 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AI393106 pooled .a 1742 to 2134 396 to 4       393/396
(99 %)
0 diff
(100 %id)
DA153905 amygdala .a 1751 to 2246 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
BQ219829 epithelioid carcinoma, Pancreas .a 1753 to 2605 1 to 859       859/863
(99 %)
8 diff
(99.1 %id)
AU185090 skin .a 1771 to 2096 326 to 1       326/326
(100 %)
0 diff
(100 %id)
DA938451 Spleen .a 1771 to 2365 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
BP243906 Liver .a 1775 to 2346 1 to 572       572/573
(99 %)
6 diff
(99.0 %id)
AI347756 2 pooled tumors (clear cell type), Kidney .a 1777 to 2134 365 to 8       358/365
(98 %)
0 diff
(100 %id)
DA676823   .a 1795 to 2355 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AL600856   .a 1803 to 2386 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP386207 pancreatic islet .a 1815 to 2126 1 to 312     Submitted on the opposite strand 312/312
(100 %)
0 diff
(100 %id)
AW104106 ovary, tumor, 5 pooled (see description) .a 1818 to 2134 322 to 6       317/322
(98 %)
0 diff
(100 %id)
BF970114 adrenal cortex carcinoma, cell line, adrenal gland .a 1832 to 2134 1 to 300   AAA   300/300
(100 %)
6 diff
(98.0 %id)
BX479655   .a 1868 to 2543 1 to 680       680/683
(99 %)
14 diff
(98.0 %id)
BE866972 adenocarcinoma, colon .a 1879 to 2621 1 to 727       727/727
(100 %)
21 diff
(97.2 %id)
BU175084 eye, retinoblastoma .a 1881 to 2518 1 to 663       663/840
(78 %)
48 diff
(94.3 %id)
T74938 Liver .a 1883 to 1947 1 to 65       65/65
(100 %)
0 diff
(100 %id)
AW364469 denis_drash .a 1893 to 2406 1 to 516       516/516
(100 %)
10 diff
(98.1 %id)
AA668629 bone marrow stroma .a 1897 to 2105 209 to 1       209/209
(100 %)
0 diff
(100 %id)
DB249789 uterus .a 1920 to 2427 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
BG116570 duodenal adenocarcinoma, cell line, small intestine .a 1926 to 2579 1 to 645       645/912
(70 %)
20 diff
(97.9 %id)
CV570807 cornea, eye .a 1937 to 2549 1 to 613       613/613
(100 %)
0 diff
(100 %id)
DA598155   .a 1947 to 2429 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
AA360871   .a 1982 to 2302 1 to 320       320/320
(100 %)
3 diff
(99.1 %id)
DT219058 brain .a 1989 to 2633 1 to 645       645/645
(100 %)
0 diff
(100 %id)
DA628538 Kidney .a 2022 to 2556 2 to 538   capped   537/537
(100 %)
5 diff
(99.1 %id)
T58640 placenta .a 2038 to 2429 403 to 1       403/429
(93 %)
13 diff
(97.0 %id)
BP293382 lung .a 2070 to 2652 1 to 586       586/586
(100 %)
13 diff
(97.8 %id)
BP198066 adrenal gland .a 2072 to 2653 1 to 582       582/582
(100 %)
0 diff
(100 %id)
R99518 liver and spleen .a 2102 to 2543 1 to 454       454/454
(100 %)
16 diff
(96.5 %id)
BX505093   .a 2108 to 2647 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
BP266657 thyroid .a 2108 to 2684 1 to 579       579/579
(100 %)
5 diff
(99.2 %id)
BU522107 leiomyosarcoma, uterus .a 2110 to 2915 1 to 819       819/830
(98 %)
10 diff
(98.8 %id)
DA581538 lung .a 2124 to 2677 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
AI821200   .a 2125 to 2589 1 to 465       465/465
(100 %)
0 diff
(100 %id)
AI792304   .a 2125 to 2625 1 to 501       501/501
(100 %)
0 diff
(100 %id)
DA068860 cerebellum .a 2126 to 2689 2 to 568   capped   567/567
(100 %)
4 diff
(99.3 %id)
AU279840   .a 2131 to 2694 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BI551086 brain, hippocampus .a 2207 to 2896 1 to 690       690/690
(100 %)
3 diff
(99.6 %id)
DA552068   .a 2223 to 2736 2 to 516   capped   515/515
(100 %)
1 diff
(99.9 %id)
BG032484 breast, mammary adenocarcinoma, cell line .a 2255 to 2916 1 to 662       662/964
(68 %)
7 diff
(99.3 %id)
BP239698 Liver .a 2262 to 2867 1 to 606       606/606
(100 %)
6 diff
(99.1 %id)
DA044530 bladder .a 2269 to 2823 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA381733 thalamus .a 2270 to 2828 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BU845347 ovary, teratocarcinoma, cell line .a 2297 to 3220 1 to 931       931/936
(99 %)
10 diff
(99.0 %id)
AW366288 head_neck .a 2314 to 2664 15 to 364       350/364
(96 %)
16 diff
(95.7 %id)
BI911450 leukocyte .a 2380 to 3243 11 to 891       881/1111
(79 %)
38 diff
(96.6 %id)
TI_57232292   .a 2380 to 3243 11 to 891       881/1111
(79 %)
38 diff
(96.6 %id)
DB255479 uterus .a 2407 to 2979 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BP298155   .a 2427 to 3008 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BG120007 adenocarcinoma, cell line, Liver .a 2432 to 2908 1 to 476       476/889
(53 %)
14 diff
(98.5 %id)
DA968807 stomach .a 2460 to 3007 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BP265196 thyroid .a 2480 to 3055 1 to 579       579/579
(100 %)
3 diff
(99.5 %id)
BQ312041 breast_normal .a 2488 to 2859 1 to 377       377/377
(100 %)
15 diff
(96.1 %id)
DA539477 Kidney .a 2495 to 3091 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
AA190516   .a 2507 to 2870 1 to 365       365/365
(100 %)
1 diff
(99.8 %id)
BP220055 colon .a 2530 to 3023 1 to 495       495/590
(83 %)
5 diff
(99.2 %id)
BQ947261 sciatic nerve .a 2530 to 3436 1 to 911       911/913
(99 %)
11 diff
(98.8 %id)
R13998 whole brain .a 2550 to 2970 1 to 432       432/507
(85 %)
20 diff
(96.1 %id)
TI_57238007   .a 2552 to 3430 36 to 913       878/946
(92 %)
34 diff
(96.5 %id)
BX480244   .a 2553 to 3059 1 to 507       507/507
(100 %)
4 diff
(99.3 %id)
Z44428 brain, total brain .a 2557 to 2845 1 to 289       289/289
(100 %)
0 diff
(100 %id)
BQ343956 nervous_tumor .a 2558 to 2933 1 to 376       376/376
(100 %)
9 diff
(97.7 %id)
R59924 whole brain .a 2558 to 3012 1 to 462     Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 462/468
(98 %)
16 diff
(96.6 %id)
AW889080 nervous_tumor .a 2559 to 2929 1 to 370       370/370
(100 %)
2 diff
(99.5 %id)
BI909869 leukocyte .a 2559 to 3430 1 to 871       871/904
(96 %)
31 diff
(96.6 %id)
BM562485 duodenal adenocarcinoma, cell line, small intestine .a 2559 to 3469 1 to 920       920/1039
(88 %)
24 diff
(97.7 %id)
DR762199 embryonic stem .a 2559 to 3420 1 to 862       862/862
(100 %)
0 diff
(100 %id)
AW889143 nervous_tumor .a 2563 to 3044 18 to 496       479/496
(96 %)
6 diff
(98.8 %id)
AW889307 nervous_tumor .a 2563 to 2886 14 to 337       324/337
(96 %)
6 diff
(98.3 %id)
AW889256 nervous_tumor .a 2571 to 2891 1 to 321       321/321
(100 %)
0 diff
(100 %id)
BE093609 breast .a 2571 to 3026 457 to 2     Submitted on the opposite strand 456/457
(99 %)
0 diff
(100 %id)
BE093600 breast .a 2574 to 3016 1 to 443       443/443
(100 %)
9 diff
(98.0 %id)
TI_154072601   .a 2608 to 3204 684 to 89       596/699
(85 %)
0 diff
(100 %id)
BG401301 Kidney .a 2610 to 3221 1 to 615       615/615
(100 %)
10 diff
(98.4 %id)
CD515063 White Matter .a 2653 to 3390 1 to 740       740/892
(82 %)
9 diff
(99.0 %id)
BM828273 stomach .a 2656 to 3056 1 to 401       401/401
(100 %)
4 diff
(99.1 %id)
BQ343955 nervous_tumor .a 2659 to 3052 397 to 5       393/397
(98 %)
0 diff
(100 %id)
BG287260 bladder, transitional cell papilloma, cell line .a 2666 to 3395 1 to 720       720/969
(74 %)
23 diff
(97.7 %id)
BE910726 epithelioid carcinoma, Pancreas .a 2677 to 3316 1 to 638       638/844
(75 %)
46 diff
(94.6 %id)
BE895604 melanotic melanoma, skin .a 2682 to 3338 1 to 650       650/826
(78 %)
15 diff
(98.2 %id)
BG500389 adenocarcinoma, Prostate .a 2703 to 3493 1 to 793       793/797
(99 %)
23 diff
(97.2 %id)
N55854   .a 2704 to 3041 1 to 337       337/337
(100 %)
7 diff
(98.0 %id)
AW889311 nervous_tumor .a 2717 to 3052 337 to 3       335/337
(99 %)
0 diff
(100 %id)
AW889190 nervous_tumor .a 2726 to 3051 330 to 5       326/330
(98 %)
0 diff
(100 %id)
R99519 liver and spleen .a 2727 to 3117 394 to 1       394/394
(100 %)
9 diff
(97.8 %id)
AW889313 nervous_tumor .a 2729 to 3051 330 to 10       321/330
(97 %)
0 diff
(100 %id)
BE763078 nervous_tumor .a 2731 to 3044 317 to 1       317/317
(100 %)
15 diff
(95.3 %id)
AW889350 nervous_tumor .a 2733 to 3044 316 to 1       316/316
(100 %)
11 diff
(96.6 %id)
BG288653 bladder, transitional cell papilloma, cell line .a 2766 to 3420 1 to 647       647/815
(79 %)
39 diff
(95.3 %id)
BQ356288 head_neck .a 2770 to 3209 442 to 5       438/442
(99 %)
0 diff
(100 %id)
BE763077 nervous_tumor .a 2771 to 3044 275 to 1       275/275
(100 %)
2 diff
(99.3 %id)
CN265112 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2774 to 3392 9 to 632       624/632
(98 %)
5 diff
(99.3 %id)
BG290651 bladder, transitional cell papilloma, cell line .a 2779 to 3467 1 to 698       698/1117
(62 %)
30 diff
(97.4 %id)
BP255549 Kidney .a 2797 to 3378 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM766983 stomach .a 2830 to 3470 1 to 641       641/641
(100 %)
0 diff
(100 %id)
AA336924 endometrium .a 2852 to 3109 1 to 258       258/258
(100 %)
0 diff
(100 %id)
AA337492 endometrium .a 2852 to 3173 1 to 322       322/322
(100 %)
0 diff
(100 %id)
BQ343957 nervous_tumor .a 2855 to 3051 203 to 8       196/203
(96 %)
0 diff
(100 %id)
AW517888 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2861 to 3218 369 to 11   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 359/359
(100 %)
1 diff
(99.8 %id)
BG282514 adenocarcinoma, cell line, Prostate .a 2877 to 3656 1 to 774       774/785
(98 %)
21 diff
(97.4 %id)
BE815030 breast_normal .a 2878 to 3414 545 to 6       540/545
(99 %)
0 diff
(100 %id)
CD612012   .a 2918 to 3606 1 to 689       689/689
(100 %)
0 diff
(100 %id)
BM757837 stomach .a 2918 to 3496 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BM750015 stomach .a 2919 to 3528 1 to 608       608/608
(100 %)
2 diff
(99.7 %id)
BF724859 eye, Iris .a 2922 to 3487 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BE905042 epithelioid carcinoma, Pancreas .a 2942 to 3806 1 to 856       856/892
(95 %)
42 diff
(95.3 %id)
BP206296 coronary artery .a 2960 to 3509 1 to 550       550/561
(98 %)
5 diff
(99.2 %id)
BF968768 adrenal cortex carcinoma, cell line, adrenal gland .a 2971 to 3724 1 to 748       748/952
(78 %)
18 diff
(98.2 %id)
BU940684 mixed (pool of 40 RNAs) .a 2979 to 3808 1 to 843       843/867
(97 %)
44 diff
(95.0 %id)
BM743886 Ascites, stomach .a 3002 to 3575 1 to 573       573/573
(100 %)
3 diff
(99.5 %id)
BE621068 epithelioid carcinoma, Pancreas .a 3006 to 3730 1 to 715       715/946
(75 %)
23 diff
(97.6 %id)
CB144852 Liver .a 3009 to 3195 1 to 187       187/187
(100 %)
3 diff
(98.4 %id)
CD612011   .a 3039 to 3796 763 to 8       756/763
(99 %)
0 diff
(100 %id)
BP329972 rectum .a 3069 to 3396 1 to 328       328/587
(55 %)
3 diff
(99.5 %id)
AU120706 whole embryo, mainly body .a 3075 to 3852 2 to 774   fully sequenced, capped   773/773
(100 %)
4 diff
(99.5 %id)
CB119533 Liver .a 3083 to 3648 1 to 566       566/566
(100 %)
0 diff
(100 %id)
CB122211 Liver .a 3087 to 3500 1 to 414       414/414
(100 %)
9 diff
(97.9 %id)
BE180960 head_neck .a 3108 to 3400 298 to 6     Submitted on the opposite strand 293/325
(90 %)
0 diff
(100 %id)
AA291974 ovarian tumor, ovary .a 3192 to 3631 1 to 439     Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 439/440
(99 %)
3 diff
(99.4 %id)
BG168690 hypernephroma, cell line, Kidney .a 3194 to 3890 1 to 701       701/1000
(70 %)
14 diff
(98.6 %id)
R55403 breast .a 3205 to 3655 1 to 466       466/466
(100 %)
25 diff
(94.7 %id)
AA111845 muscle, skeletal muscle .a 3217 to 3596 1 to 381       381/381
(100 %)
1 diff
(99.8 %id)
BG109944 Bone, osteosarcoma, cell line .a 3217 to 3974 1 to 751       751/923
(81 %)
12 diff
(98.7 %id)
N71270 liver and spleen .a 3224 to 3686 1 to 472     Submitted on the opposite strand 472/472
(100 %)
16 diff
(96.7 %id)
N73758 liver and spleen .a 3224 to 3878 1 to 661     Submitted on the opposite strand 661/665
(99 %)
30 diff
(95.5 %id)
CN265109 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3231 to 3567 1 to 337       337/337
(100 %)
0 diff
(100 %id)
H93974 liver and spleen .a 3232 to 3597 1 to 372     Submitted on the opposite strand 372/409
(90 %)
8 diff
(98.1 %id)
BF915429 uterus_tumor .a 3234 to 3830 1 to 590       590/594
(99 %)
23 diff
(96.2 %id)
H66349 liver and spleen .a 3237 to 3576 1 to 353     Submitted on the opposite strand 353/386
(91 %)
14 diff
(96.4 %id)
AU122970   .a 3247 to 3846 2 to 611   capped   610/738
(82 %)
16 diff
(97.9 %id)
AA233246 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3254 to 3684 1 to 431     Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 431/431
(100 %)
2 diff
(99.6 %id)
AA478704 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3254 to 3684 1 to 431       431/431
(100 %)
0 diff
(100 %id)
DR422931 eye, Pterygium .a 3263 to 3985 1 to 719       719/719
(100 %)
5 diff
(99.4 %id)
BQ311268 breast_normal .a 3312 to 3613 310 to 5       306/366
(83 %)
0 diff
(100 %id)
AA236121 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3318 to 3628 1 to 310       310/310
(100 %)
1 diff
(99.7 %id)
AW375607 colon .a 3335 to 3991 14 to 668       655/670
(97 %)
11 diff
(98.4 %id)
AW375646 colon .a 3341 to 3648 312 to 7       306/312
(98 %)
0 diff
(100 %id)
AW846342 colon .a 3343 to 3922 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
AW846504 colon .a 3348 to 3739 1 to 389       389/389
(100 %)
6 diff
(98.5 %id)
BM785424 Ascites, stomach .a 3351 to 3983 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
BE811042 amnion_normal .a 3370 to 3740 1 to 372       372/372
(100 %)
6 diff
(98.4 %id)
BF818197 colon_ins .a 3371 to 3824 457 to 5     Submitted on the opposite strand 453/475
(95 %)
0 diff
(100 %id)
BE811035 amnion_normal .a 3377 to 3705 1 to 329       329/329
(100 %)
2 diff
(99.4 %id)
BE811039 amnion_normal .a 3377 to 3743 1 to 367       367/369
(99 %)
3 diff
(99.2 %id)
BQ291718 amnion_normal .a 3387 to 3734 1 to 354       354/354
(100 %)
10 diff
(97.2 %id)
BF771815 epid_tumor .a 3400 to 3852 9 to 465       457/467
(97 %)
11 diff
(97.7 %id)
TI_149284551   .a 3400 to 4305 968 to 62   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 907/1104
(82 %)
36 diff
(96.8 %id)
BP318691 pericardium .a 3471 to 4056 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
BM852893 Ascites, stomach .a 3486 to 3929 1 to 444       444/444
(100 %)
0 diff
(100 %id)
AA399493   .a 3511 to 3870 1 to 356   fully sequenced,   356/356
(100 %)
6 diff
(98.4 %id)
AW385024 head_neck .a 3519 to 3949 12 to 442       431/457
(94 %)
10 diff
(97.9 %id)
BF926025 nervous_tumor .a 3520 to 3997 19 to 496       478/506
(94 %)
17 diff
(96.7 %id)
BQ374782 testis_normal .a 3541 to 3983 445 to 1       445/471
(94 %)
7 diff
(98.6 %id)
FN133430 breast carcinoma .a 3551 to 3620 1 to 69       69/69
(100 %)
1 diff
(98.6 %id)
AW375623 colon .a 3559 to 4172 613 to 5       609/615
(99 %)
0 diff
(100 %id)
CA312526 Human Lung Epithelial cells, lung .a 3560 to 4305 764 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 746/746
(100 %)
1 diff
(99.9 %id)
BU607610 Human Lung Epithelial cells, lung .a 3571 to 4305 753 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 735/735
(100 %)
5 diff
(99.4 %id)
AW846348 colon .a 3583 to 4175 597 to 4       594/598
(99 %)
0 diff
(100 %id)
CA314697 Human Lung Epithelial cells, lung .a 3588 to 4305 735 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 717/753
(95 %)
5 diff
(99.4 %id)
BU617028 Cell Line, Chondrosarcoma .a 3589 to 4305 734 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 716/716
(100 %)
3 diff
(99.6 %id)
BM997180 Chondrosarcoma, Left Pubic Bone .a 3593 to 4305 730 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 712/712
(100 %)
4 diff
(99.5 %id)
CA307149 Alveolar Macrophage, lung .a 3593 to 4305 730 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 712/712
(100 %)
3 diff
(99.6 %id)
CF596523 Stomach, adenocarcinoma .a 3596 to 4129 1 to 543       543/867
(62 %)
21 diff
(97.6 %id)
BQ446306 Knee, Osteoarthritic Cartilage .a 3610 to 4305 713 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 695/696
(99 %)
4 diff
(99.5 %id)
BU630973 cell lines, Chondrosarcoma .a 3610 to 4305 714 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 696/699
(99 %)
2 diff
(99.8 %id)
BU626687 Alveolar Macrophage, lung .a 3610 to 4305 714 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 696/699
(99 %)
3 diff
(99.6 %id)
BQ447053 Knee, Osteoarthritic Cartilage .a 3612 to 4309 715 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 697/697
(100 %)
1 diff
(99.9 %id)
CA419791 Bone, Human Chondrosarcoma Cell Line .a 3613 to 4305 711 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 693/693
(100 %)
7 diff
(99.0 %id)
BU619294 Cell Line, Chondrosarcoma .a 3613 to 4305 710 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 692/693
(99 %)
6 diff
(99.2 %id)
BX101460 liver and spleen .a 3617 to 4305 704 to 15   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 690/690
(100 %)
2 diff
(99.8 %id)
AW970638   .a 3626 to 4304 676 to 1     Submitted on the opposite strand 676/681
(99 %)
22 diff
(96.8 %id)
FN089553 breast carcinoma .a 3627 to 3724 1 to 94       94/96
(97 %)
5 diff
(94.8 %id)
FN052357 breast carcinoma .a 3642 to 3743 102 to 1     Submitted on the opposite strand 102/102
(100 %)
0 diff
(100 %id)
AW846345 colon .a 3648 to 4173 532 to 7       526/532
(98 %)
0 diff
(100 %id)
BM694926 eye, RPE and Choroid .a 3657 to 4174 1 to 517       517/526
(98 %)
2 diff
(99.7 %id)
BE002934 breast_normal .a 3666 to 4011 347 to 3     Submitted on the opposite strand 345/347
(99 %)
0 diff
(100 %id)
BU680583 lung, Primary Lung Epithelial Cells .a 3672 to 4305 653 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 635/635
(100 %)
3 diff
(99.6 %id)
AA082153 heart .a 3710 to 3857 1 to 148   fully sequenced,   148/148
(100 %)
3 diff
(98.0 %id)
AA523414 colon .a 3711 to 4306 596 to 1       596/596
(100 %)
2 diff
(99.7 %id)
BM689408 eye, Retina Foveal and Macular .a 3713 to 3892 23 to 202   fully sequenced, Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 180/202
(89 %)
5 diff
(97.6 %id)
CA398073 eye, RPE/choroid .a 3755 to 4305 567 to 17   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 551/551
(100 %)
1 diff
(99.9 %id)
BF594168 brain, glioblastoma (pooled) .a 3773 to 4305 533 to 1       533/533
(100 %)
0 diff
(100 %id)
BE350068 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 3778 to 4305 527 to 1       527/527
(100 %)
1 diff
(99.9 %id)
AI887705 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3786 to 4306 521 to 1       521/521
(100 %)
0 diff
(100 %id)
FN160562 breast carcinoma .a 3787 to 3883 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
BQ774660 Bone, Human Chondrosarcoma Cell Line .a 3788 to 4305 537 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 519/694
(74 %)
6 diff
(99.2 %id)
FN173590 breast carcinoma .a 3790 to 3885 98 to 1     Submitted on the opposite strand 98/98
(100 %)
2 diff
(98.0 %id)
TI_157614229   .a 3794 to 4309 613 to 98   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 516/516
(100 %)
11 diff
(97.9 %id)
AA669035 lung .a 3800 to 4306 507 to 1       507/507
(100 %)
0 diff
(100 %id)
AI436787 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3802 to 4305 504 to 1       504/504
(100 %)
0 diff
(100 %id)
AW846514 colon .a 3806 to 4197 392 to 3       390/392
(99 %)
0 diff
(100 %id)
FN079002 breast carcinoma .a 3806 to 3893 1 to 87       87/95
(91 %)
1 diff
(99.0 %id)
AW131072 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3818 to 4312 500 to 6       495/500
(99 %)
0 diff
(100 %id)
AU146702 whole embryo, mainly body .a 3822 to 4305 482 to 1   fully sequenced,   482/482
(100 %)
1 diff
(99.8 %id)
DB524151 testis .a 3827 to 4303 1 to 477     Submitted on the opposite strand 477/479
(99 %)
1 diff
(99.8 %id)
AA071468 heart .a 3827 to 4306 482 to 1   fully sequenced,   482/482
(100 %)
1 diff
(99.8 %id)
AA190842   .a 3827 to 4306 486 to 5       482/487
(98 %)
0 diff
(100 %id)
AI141080 lung .a 3830 to 4306 478 to 2       477/478
(99 %)
0 diff
(100 %id)
CA443777 lung, Metastatic Chondrosarcoma .a 3831 to 4309 498 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 480/480
(100 %)
1 diff
(99.8 %id)
EC525923 Prostate .a 3837 to 3933 1 to 92       92/94
(97 %)
9 diff
(90.5 %id)
AA398286   .a 3840 to 4316 478 to 1   fully sequenced,   478/478
(100 %)
7 diff
(98.6 %id)
BE857302 brain, glioblastoma (pooled) .a 3840 to 4305 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
AI346550 adenocarcinoma, colon .a 3843 to 4305 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AW105520 ovary, tumor, 5 pooled (see description) .a 3843 to 4305 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AW104670 ovary, tumor, 5 pooled (see description) .a 3843 to 4305 464 to 1       464/464
(100 %)
4 diff
(99.2 %id)
CR741908   .a 3845 to 4304 1 to 460       460/460
(100 %)
1 diff
(99.8 %id)
FN112758 breast carcinoma .a 3848 to 3953 101 to 1     Submitted on the opposite strand 101/101
(100 %)
5 diff
(95.1 %id)
R59925 whole brain .a 3849 to 4305 476 to 13   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 464/469
(98 %)
30 diff
(93.7 %id)
W03870 liver and spleen .a 3854 to 4305 461 to 1     Submitted on the opposite strand 461/466
(98 %)
11 diff
(97.7 %id)
AA478570.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3856 to 4312 464 to 7     also hits gene SF4 458/464
(98 %)
0 diff
(100 %id)
AI291764 carcinoid, lung .a 3858 to 4304 448 to 2       447/448
(99 %)
0 diff
(100 %id)
AI744242 ovary, tumor, 5 pooled (see description) .a 3858 to 4308 454 to 4       451/454
(99 %)
0 diff
(100 %id)
AI623776 adenocarcinoma, Pancreas .a 3858 to 4310 453 to 1       453/453
(100 %)
0 diff
(100 %id)
CF995354 Pooled Chondrosarcoma Tumor cells .a 3858 to 4312 9 to 463       455/496
(91 %)
6 diff
(98.8 %id)
AI088738 brain, glioblastoma (pooled) .a 3859 to 4306 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI275445 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3859 to 4305 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AI559614 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3859 to 4306 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI983370 brain, three pooled meningiomas .a 3859 to 4306 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AW130108 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3859 to 4305 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
BE207287.
matches multiple genes
lung, small cell carcinoma .a 3859 to 4305 485 to 39   AAA Submitted on the opposite strand, also hits gene ARMC6 447/447
(100 %)
0 diff
(100 %id)
AW874023 follicular carcinoma, thyroid .a 3859 to 4305 465 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 447/447
(100 %)
1 diff
(99.8 %id)
AI017354 Kidney .a 3861 to 4305 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
AA775703 heart .a 3862 to 4305 446 to 1       446/446
(100 %)
8 diff
(98.3 %id)
AI523044 aorta .a 3862 to 4305 444 to 1       444/444
(100 %)
0 diff
(100 %id)
BF445883 Prostate .a 3862 to 4308 450 to 4       447/450
(99 %)
0 diff
(100 %id)
BU726572 eye, Retina Foveal and Macular .a 3862 to 4305 462 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 444/444
(100 %)
0 diff
(100 %id)
AI342477 uterus .a 3863 to 4306 448 to 5       444/448
(99 %)
0 diff
(100 %id)
AI623147 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3863 to 4305 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI887698 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3863 to 4306 444 to 1       444/444
(100 %)
4 diff
(99.1 %id)
AW008384 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3863 to 4312 452 to 3       450/452
(99 %)
0 diff
(100 %id)
AA086290 muscle, skeletal muscle .a 3864 to 4306 444 to 2       443/444
(99 %)
0 diff
(100 %id)
AA975888 carcinoid, lung .a 3864 to 4257 437 to 47       391/437
(89 %)
0 diff
(100 %id)
AI189262 uterus .a 3871 to 4305 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AA630015 lung, lung carcinoma .a 3873 to 4305 433 to 1       433/433
(100 %)
0 diff
(100 %id)
R87163 liver and spleen .a 3874 to 4306 444 to 1     Submitted on the opposite strand 444/454
(97 %)
15 diff
(96.7 %id)
AA974061 carcinoid, lung .a 3876 to 4306 434 to 4       431/434
(99 %)
0 diff
(100 %id)
BU858913 mixed (pool of 40 RNAs) .a 3878 to 4306 1 to 429       429/431
(99 %)
3 diff
(99.4 %id)
AI859926 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3881 to 4304 424 to 1       424/424
(100 %)
0 diff
(100 %id)
AA146716 colon, tumor .a 3883 to 4305 424 to 1       424/427
(99 %)
4 diff
(99.1 %id)
AI056642 liver and spleen .a 3883 to 4312 435 to 6       430/436
(98 %)
0 diff
(100 %id)
BQ005203 Chondrosarcoma, Left Pelvis .a 3885 to 4305 440 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 422/422
(100 %)
1 diff
(99.8 %id)
AI367605 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3886 to 4305 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AI139508 uterus .a 3892 to 4305 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AI087177 senescent fibroblast .a 3894 to 4309 437 to 22   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 416/416
(100 %)
1 diff
(99.8 %id)
AI368430 brain, glioblastoma (pooled) .a 3894 to 4305 415 to 1       415/415
(100 %)
3 diff
(99.3 %id)
AW270051 lung, two pooled squamous cell carcinomas .a 3895 to 4305 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
AI130022 uterus .a 3899 to 4306 409 to 2       408/409
(99 %)
0 diff
(100 %id)
AI150090   .a 3899 to 4307 414 to 6       409/414
(98 %)
0 diff
(100 %id)
AI274258 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3899 to 4305 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AI287564 placenta .a 3899 to 4306 411 to 4       408/411
(99 %)
0 diff
(100 %id)
AI926376 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3899 to 4306 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AA927973 adenocarcinoma, colon .a 3900 to 4306 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AI625760 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3900 to 4305 428 to 23   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 406/406
(100 %)
0 diff
(100 %id)
FN065152 breast carcinoma .a 3901 to 4001 106 to 1     Submitted on the opposite strand 106/106
(100 %)
4 diff
(96.3 %id)
AI002761   .a 3901 to 4307 413 to 6       408/413
(98 %)
0 diff
(100 %id)
DB507428 testis .a 3902 to 4305 1 to 404     Submitted on the opposite strand 404/404
(100 %)
4 diff
(99.1 %id)
AI088593 uterus .a 3902 to 4305 404 to 1       404/404
(100 %)
0 diff
(100 %id)
BE856466 Prostate .a 3907 to 4306 401 to 2       400/401
(99 %)
0 diff
(100 %id)
W42871.
matches multiple genes
senescent fibroblast .a 3910 to 4305 399 to 1     also hits gene FKBP9L 399/403
(99 %)
3 diff
(99.3 %id)
R39121 whole brain .a 3914 to 4312 402 to 3       400/572
(69 %)
0 diff
(100 %id)
H66399 liver and spleen .a 3916 to 4306 394 to 2     Submitted on the opposite strand 393/394
(99 %)
0 diff
(100 %id)
R55305 breast .a 3925 to 4306 390 to 1       390/399
(97 %)
16 diff
(96.0 %id)
AA535172 invasive prostate tumor, Prostate .a 3927 to 4305 405 to 30   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 376/440
(85 %)
5 diff
(98.9 %id)
AA233170 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3932 to 4309 389 to 11   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 379/379
(100 %)
2 diff
(99.5 %id)
AI625205 adenocarcinoma, Pancreas .a 3932 to 4307 378 to 3       376/378
(99 %)
0 diff
(100 %id)
W01614 liver and spleen .a 3942 to 4305 380 to 12   AAA Submitted on the opposite strand 434/486
(89 %)
20 diff
(95.9 %id)
AI590421 adenocarcinoma, Pancreas .a 3942 to 4309 368 to 1       368/368
(100 %)
2 diff
(99.5 %id)
AA878587 2 pooled tumors (clear cell type), Kidney .a 3944 to 4306 365 to 3       363/365
(99 %)
0 diff
(100 %id)
AI359423 brain, glioblastoma (pooled) .a 3946 to 4305 360 to 1       360/360
(100 %)
0 diff
(100 %id)
AI141406 brain, glioblastoma (pooled) .a 3951 to 4305 403 to 48   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 356/357
(99 %)
40 diff
(88.8 %id)
AI358399 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 3951 to 4305 355 to 1       355/355
(100 %)
5 diff
(98.6 %id)
BE328315 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 3952 to 4309 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
Z40355 brain, total brain .a 3956 to 4305 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
FN142648 breast carcinoma .a 3961 to 4070 112 to 1     Submitted on the opposite strand 112/113
(99 %)
5 diff
(95.6 %id)
AI346619 adenocarcinoma, colon .a 3961 to 4305 345 to 1       345/345
(100 %)
0 diff
(100 %id)
FN053212 breast carcinoma .a 3971 to 4078 107 to 1     Submitted on the opposite strand 107/108
(99 %)
1 diff
(99.1 %id)
AI749243 colon .a 3971 to 4306 337 to 3       335/348
(96 %)
0 diff
(100 %id)
FN078054 breast carcinoma .a 3976 to 4069 1 to 95       95/96
(98 %)
2 diff
(98.0 %id)
AW009423 colon .a 3980 to 4306 328 to 2       327/328
(99 %)
0 diff
(100 %id)
AA928378 pooled germ cell tumors .a 3981 to 4305 325 to 1       325/325
(100 %)
0 diff
(100 %id)
AI827134 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3981 to 4305 344 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 326/326
(100 %)
4 diff
(98.8 %id)
BF447388 sympathetic trunk .a 3982 to 4306 325 to 1       325/325
(100 %)
0 diff
(100 %id)
R95813 liver and spleen .a 3989 to 4305 322 to 2     Submitted on the opposite strand 321/322
(99 %)
0 diff
(100 %id)
AI758975 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3991 to 4306 316 to 1       316/317
(99 %)
2 diff
(99.4 %id)
C20665   .a 3995 to 4293 1 to 303       303/303
(100 %)
7 diff
(97.7 %id)
CF528342 placenta .a 4001 to 4309 326 to 18   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 309/314
(98 %)
1 diff
(99.7 %id)
FN062016 breast carcinoma .a 4002 to 4062 1 to 63       63/64
(98 %)
3 diff
(95.4 %id)
DB513519 testis .a 4009 to 4305 1 to 296     Submitted on the opposite strand 296/296
(100 %)
11 diff
(96.3 %id)
AU185759 skin .a 4010 to 4305 1 to 296       296/296
(100 %)
0 diff
(100 %id)
AU185760 skin .a 4010 to 4305 296 to 1       296/296
(100 %)
0 diff
(100 %id)
AI857297 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 4017 to 4305 304 to 16   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 289/289
(100 %)
0 diff
(100 %id)
AI419528 brain, glioblastoma (pooled) .a 4022 to 4305 284 to 1       284/284
(100 %)
0 diff
(100 %id)
AA236152 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4023 to 4305 285 to 1       285/285
(100 %)
5 diff
(98.3 %id)
AW006551 Prostate .a 4037 to 4306 275 to 5       271/275
(98 %)
0 diff
(100 %id)
AA622070 colon, colon tumor RER+ .a 4049 to 4141 93 to 1       93/93
(100 %)
0 diff
(100 %id)
H93973 liver and spleen .a 4055 to 4306 256 to 5     Submitted on the opposite strand 252/256
(98 %)
0 diff
(100 %id)
AW873402 normal epithelium, thyroid .a 4066 to 4309 300 to 57   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 244/244
(100 %)
4 diff
(98.4 %id)
AI283740 Kidney .a 4089 to 4312 226 to 3       224/226
(99 %)
0 diff
(100 %id)
AI382720 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4090 to 4305 217 to 1       217/217
(100 %)
1 diff
(99.6 %id)
AW168526 bowel (skin primary), metastatic melanoma to bowel .a 4092 to 4311 221 to 1       221/221
(100 %)
5 diff
(97.8 %id)
BU609057 Human Lung Epithelial cells, lung .a 4099 to 4305 226 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 208/229
(90 %)
2 diff
(99.2 %id)
AA293316 ovarian tumor, ovary .a 4101 to 4309 226 to 18   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 209/209
(100 %)
0 diff
(100 %id)
BQ306925 breast .a 4108 to 4306 17 to 217   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 201/219
(91 %)
12 diff
(94.6 %id)
BU609211 Human Lung Epithelial cells, lung .a 4110 to 4305 215 to 19   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 197/197
(100 %)
1 diff
(99.5 %id)
AW105516 ovary, tumor, 5 pooled (see description) .a 4125 to 4305 182 to 1       182/182
(100 %)
6 diff
(96.8 %id)
AI732185   .a 4129 to 4581 455 to 3       453/455
(99 %)
0 diff
(100 %id)
FN162041 breast carcinoma .a 4135 to 4249 1 to 117       117/117
(100 %)
2 diff
(98.3 %id)
FN088086 breast carcinoma .a 4152 to 4241 93 to 1     Submitted on the opposite strand 93/94
(98 %)
3 diff
(96.9 %id)
FN118946 breast carcinoma .a 4181 to 4286 1 to 107       107/107
(100 %)
2 diff
(98.2 %id)
AW630153 2 pooled high-grade transitional celltumors, genitourinary tract .a 4205 to 4309 1 to 105   fully sequenced, AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 105/105
(100 %)
0 diff
(100 %id)
CB134019 Liver .a 4213 to 4744 1 to 532   tiling clone,   532/532
(100 %)
4 diff
(99.3 %id)
CB133647 Liver .a 4213 to 4739 1 to 527   tiling clone,   527/528
(99 %)
5 diff
(99.1 %id)
AA598577   .a 4234 to 4581 348 to 1       348/348
(100 %)
2 diff
(99.5 %id)
CB136808 Liver .a 4244 to 4600 1 to 357       357/357
(100 %)
0 diff
(100 %id)
AW613581 2 pooled high-grade transitional celltumors, genitourinary tract .a 4256 to 4310 55 to 1   fully sequenced, Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 55/55
(100 %)
0 diff
(100 %id)
AA776554   .a 4420 to 4581 162 to 1       162/162
(100 %)
0 diff
(100 %id)
AA789044 bone marrow stroma .a 4483 to 4985 502 to 1   tiling clone,   502/502
(100 %)
9 diff
(98.3 %id)
CR603161 Placenta Cot 25-normalized .b 1 to 1756 1 to 1756 exact tiling clone,   1756/1756
(100 %)
0 diff
(100 %id)
AL543336 placenta, Placenta Cot 25-normalized .b 1 to 867 1 to 868   fully sequenced,   868/868
(100 %)
1 diff
(99.9 %id)
BF969803 adrenal cortex carcinoma, cell line, adrenal gland .b 3 to 678 1 to 674       674/724
(93 %)
9 diff
(98.8 %id)
CN265111 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 13 to 377 1 to 365       365/365
(100 %)
2 diff
(99.5 %id)
AL036221 brain .b 59 to 714 1 to 662       662/673
(98 %)
11 diff
(98.4 %id)
CA391344 eye, RPE/choroid .b 81 to 713 1 to 633       633/633
(100 %)
0 diff
(100 %id)
BQ307360 breast .b 85 to 618 40 to 574       535/574
(93 %)
10 diff
(98.3 %id)
BM905033 melanotic melanoma, skin .b 96 to 1012 1 to 920       920/951
(96 %)
16 diff
(98.4 %id)
DB148485 thymus .b 136 to 690 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CB956372 Pooled-Glandular .b 199 to 994 1 to 798       798/799
(99 %)
7 diff
(99.2 %id)
CA389226 eye, RPE/choroid .b 248 to 666 1 to 419       419/419
(100 %)
0 diff
(100 %id)
DB218269 trachea .b 258 to 786 2 to 531   capped   530/530
(100 %)
2 diff
(99.7 %id)
BI012886 lung_tumor .b 328 to 670 348 to 2       347/348
(99 %)
11 diff
(96.9 %id)
BF242834 bone marrow, from acute myelogenous leukemia .b 332 to 921 1 to 597       597/827
(72 %)
17 diff
(98.0 %id)
H57074 liver and spleen .b 412 to 566 1 to 154       154/154
(100 %)
2 diff
(98.8 %id)
DA195272 amygdala .b 430 to 930 2 to 502   capped   501/501
(100 %)
1 diff
(99.9 %id)
AA374822 lung .b 476 to 807 1 to 332       332/334
(99 %)
4 diff
(98.9 %id)
DA992396 synovial membrane tissue from rheumatioidarthritis .b 479 to 1029 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BE971084 muscle (skeletal) .b 490 to 1170 1 to 680       680/680
(100 %)
48 diff
(93.0 %id)
BE971462 muscle (skeletal) .b 490 to 1126 1 to 630       632/634
(99 %)
15 diff
(97.7 %id)
BE971482 muscle (skeletal) .b 490 to 1199 1 to 721       721/822
(87 %)
40 diff
(95.2 %id)
BE971324 muscle (skeletal) .b 490 to 1103 1 to 619       617/619
(99 %)
14 diff
(97.8 %id)
DA340823 substantia nigra .b 526 to 1071 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA757245   .b 596 to 1161 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
CB161269 Liver .b 614 to 1154 1 to 541       541/541
(100 %)
0 diff
(100 %id)
AW994370 breast_normal .b 627 to 1095 1 to 467       467/473
(98 %)
9 diff
(98.1 %id)
BE765055 nervous_tumor .b 661 to 1012 14 to 367       354/377
(93 %)
25 diff
(93.4 %id)
BF735126 amnion_normal .b 662 to 1014 351 to 1     Submitted on the opposite strand 351/351
(100 %)
3 diff
(99.2 %id)
AA366495 Pancreas .b 692 to 922 1 to 231       231/231
(100 %)
0 diff
(100 %id)
FN164442 breast carcinoma .b 709 to 806 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
BE762980 nervous_tumor .b 734 to 1015 299 to 22       278/299
(92 %)
0 diff
(100 %id)
CB134112 Liver .b 765 to 1400 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
H89334 cochlea, ear .b 813 to 1136 1 to 328       328/328
(100 %)
5 diff
(98.5 %id)
AL569891 placenta, Placenta Cot 25-normalized .b 837 to 1756 919 to 1   fully sequenced,   919/919
(100 %)
1 diff
(99.9 %id)
AW361174 colon .b 930 to 1191 496 to 235       263/496
(53 %)
0 diff
(100 %id)
AI565496 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 943 to 1487 580 to 36   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 545/545
(100 %)
15 diff
(97.3 %id)
AA852068 brain .b 986 to 1130 145 to 1       145/145
(100 %)
0 diff
(100 %id)
BP393084 pancreatic islet .b 988 to 1487 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
EH341572   .b 1041 to 1105 1 to 65       65/68
(95 %)
2 diff
(97.1 %id)
BE181560 head_neck .b 1161 to 1294 77 to 210       134/210
(63 %)
6 diff
(97.2 %id)
CF596052 Stomach, adenocarcinoma .b 1218 to 1487 1 to 270   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 270/270
(100 %)
3 diff
(98.9 %id)
H89335 cochlea, ear .b 1233 to 1486 259 to 6       254/259
(98 %)
0 diff
(100 %id)
BI761986 pooled colon, kidney, stomach .b 1355 to 1799 1 to 445   AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 445/445
(100 %)
2 diff
(99.6 %id)
TI_57151124   .b 1356 to 1799 34 to 477   tiling clone, AAA Possibly primed on the genome, locally A rich (29/34 A in genome downstream of last aligned base) 444/477
(93 %)
6 diff
(98.8 %id)
U81380   .c 1 to 1098 1 to 1097 exact tiling clone,   1097/1099
(99 %)
5 diff
(99.6 %id)
AW342076 carcinoid, lung .c 633 to 1099 1 to 467   tiling clone, Submitted on the opposite strand 467/467
(100 %)
3 diff
(99.4 %id)
DB189063 liver, tumor tissue .d 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
2 diff
(99.7 %id)
AK123515 thalamus .d 344 to 2140 1 to 1797 H32R tiling clone, available from FLJ,   1797/1797
(100 %)
2 diff
(99.9 %id)
DA379962 thalamus .d 345 to 888 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
BP267254 thyroid .e 1 to 565 1 to 565 A20X L43X tiling clone,   565/565
(100 %)
1 diff
(99.9 %id)
BP268031 thyroid .e 1 to 580 1 to 576 S3T R4G E5S V6G E7R ...     576/576
(100 %)
28 diff
(95.2 %id)
CD514479 White Matter .e 20 to 320 1 to 300   tiling clone,   300/937
(32 %)
6 diff
(99.4 %id)
AL043521 testis .e 362 to 984 1 to 623   tiling clone,   623/623
(100 %)
0 diff
(100 %id)
AI820782 breast .f-u 1 to 435 1 to 435 exact tiling clone,   435/435
(100 %)
0 diff
(100 %id)
H26335 breast .f-u 1 to 403 1 to 407 exact     407/411
(99 %)
6 diff
(98.6 %id)
H26411 breast .f-u 87 to 453 371 to 1   tiling clone,   371/435
(85 %)
6 diff
(98.7 %id)
DA329674 hippocampus Gene IL13RA1, variant not shown       capped This clone was ignored    
AV645528 corresponding non cancerous liver tissue Gene IL13RA1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
  GLCABG03__1           Anomalous_clone    
AV645809 corresponding non cancerous liver tissue Gene IL13RA1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB445602 testis Gene IL13RA1, variant not shown         This clone was ignored    
BG179312 adenocarcinoma, cell line, Prostate Gene IL13RA1, variant not shown         This clone was ignored    
BG824575 adenocarcinoma cell line, colon Gene IL13RA1, variant not shown         This clone was ignored    
BQ044949 Knee, Osteoarthritic Cartilage Gene IL13RA1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI